Cargando…

Prognostic Factors and Treatment Options for Patients with High-Grade Chondrosarcoma

BACKGROUND: The goal of this study was to determine the prognostic factors exclusive for high-grade chondrosarcoma and whether adjuvant radiotherapy could achieve better overall survival (OS) or cancer-specific survival (CSS) for patients with high-grade chondrosarcoma. MATERIAL/METHODS: Surveillanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Zhongyang, Lu, Teng, Song, Hui, Gao, Zhengchao, Ren, Fenggang, Ouyang, Pengrong, Wang, Yibin, Zhu, Junjie, Zhou, Songlin, He, Xijing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894367/
https://www.ncbi.nlm.nih.gov/pubmed/31765367
http://dx.doi.org/10.12659/MSM.917959
_version_ 1783476379692564480
author Gao, Zhongyang
Lu, Teng
Song, Hui
Gao, Zhengchao
Ren, Fenggang
Ouyang, Pengrong
Wang, Yibin
Zhu, Junjie
Zhou, Songlin
He, Xijing
author_facet Gao, Zhongyang
Lu, Teng
Song, Hui
Gao, Zhengchao
Ren, Fenggang
Ouyang, Pengrong
Wang, Yibin
Zhu, Junjie
Zhou, Songlin
He, Xijing
author_sort Gao, Zhongyang
collection PubMed
description BACKGROUND: The goal of this study was to determine the prognostic factors exclusive for high-grade chondrosarcoma and whether adjuvant radiotherapy could achieve better overall survival (OS) or cancer-specific survival (CSS) for patients with high-grade chondrosarcoma. MATERIAL/METHODS: Surveillance, Epidemiology, and End Results (SEER) cancer registry database was utilized to extract the chondrosarcoma cases diagnosed between 1973 and 2014. Among these cases, the histological grades of poorly differentiated (grade 3) and undifferentiated (grade 4) were categorized as high-grade and included in this study. Chondrosarcoma OS and CSS were the primary outcomes in the present study. The log-rank test was performed for univariate analysis, and the Cox regression model was conducted for multivariate analysis. RESULTS: A total of 743 patients with high-grade chondrosarcoma were identified in this study (430 cases were poorly differentiated tumors, and 313 cases were undifferentiated tumors). Age at diagnosis, pathological grade, histo-type, SEER stage, tumor size and surgical resection were identified as independent predictors in both OS and CSS analysis of high-grade chondrosarcoma. When stratified by histological grade, surgical resection remained the effective treatment. Strikingly, radiotherapy was determined as an independent protective factor in both OS and CSS analysis of undifferentiated (grade 4) dedifferentiated chondrosarcoma, and adjuvant radiotherapy combined surgical resection could improve both the OS and CSS of patients with undifferentiated myxoid and dedifferentiated chondrosarcoma compared with other treatment regimens. CONCLUSIONS: Our study first demonstrated that adjuvant radiotherapy combined surgery could improve the survival of patients with undifferentiated myxoid and dedifferentiated chondrosarcoma. These results encourage the application of adjuvant radiotherapy for patients with high-grade chondrosarcoma and maximize the patients’ outcome.
format Online
Article
Text
id pubmed-6894367
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-68943672019-12-16 Prognostic Factors and Treatment Options for Patients with High-Grade Chondrosarcoma Gao, Zhongyang Lu, Teng Song, Hui Gao, Zhengchao Ren, Fenggang Ouyang, Pengrong Wang, Yibin Zhu, Junjie Zhou, Songlin He, Xijing Med Sci Monit Clinical Research BACKGROUND: The goal of this study was to determine the prognostic factors exclusive for high-grade chondrosarcoma and whether adjuvant radiotherapy could achieve better overall survival (OS) or cancer-specific survival (CSS) for patients with high-grade chondrosarcoma. MATERIAL/METHODS: Surveillance, Epidemiology, and End Results (SEER) cancer registry database was utilized to extract the chondrosarcoma cases diagnosed between 1973 and 2014. Among these cases, the histological grades of poorly differentiated (grade 3) and undifferentiated (grade 4) were categorized as high-grade and included in this study. Chondrosarcoma OS and CSS were the primary outcomes in the present study. The log-rank test was performed for univariate analysis, and the Cox regression model was conducted for multivariate analysis. RESULTS: A total of 743 patients with high-grade chondrosarcoma were identified in this study (430 cases were poorly differentiated tumors, and 313 cases were undifferentiated tumors). Age at diagnosis, pathological grade, histo-type, SEER stage, tumor size and surgical resection were identified as independent predictors in both OS and CSS analysis of high-grade chondrosarcoma. When stratified by histological grade, surgical resection remained the effective treatment. Strikingly, radiotherapy was determined as an independent protective factor in both OS and CSS analysis of undifferentiated (grade 4) dedifferentiated chondrosarcoma, and adjuvant radiotherapy combined surgical resection could improve both the OS and CSS of patients with undifferentiated myxoid and dedifferentiated chondrosarcoma compared with other treatment regimens. CONCLUSIONS: Our study first demonstrated that adjuvant radiotherapy combined surgery could improve the survival of patients with undifferentiated myxoid and dedifferentiated chondrosarcoma. These results encourage the application of adjuvant radiotherapy for patients with high-grade chondrosarcoma and maximize the patients’ outcome. International Scientific Literature, Inc. 2019-11-25 /pmc/articles/PMC6894367/ /pubmed/31765367 http://dx.doi.org/10.12659/MSM.917959 Text en © Med Sci Monit, 2019 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Clinical Research
Gao, Zhongyang
Lu, Teng
Song, Hui
Gao, Zhengchao
Ren, Fenggang
Ouyang, Pengrong
Wang, Yibin
Zhu, Junjie
Zhou, Songlin
He, Xijing
Prognostic Factors and Treatment Options for Patients with High-Grade Chondrosarcoma
title Prognostic Factors and Treatment Options for Patients with High-Grade Chondrosarcoma
title_full Prognostic Factors and Treatment Options for Patients with High-Grade Chondrosarcoma
title_fullStr Prognostic Factors and Treatment Options for Patients with High-Grade Chondrosarcoma
title_full_unstemmed Prognostic Factors and Treatment Options for Patients with High-Grade Chondrosarcoma
title_short Prognostic Factors and Treatment Options for Patients with High-Grade Chondrosarcoma
title_sort prognostic factors and treatment options for patients with high-grade chondrosarcoma
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894367/
https://www.ncbi.nlm.nih.gov/pubmed/31765367
http://dx.doi.org/10.12659/MSM.917959
work_keys_str_mv AT gaozhongyang prognosticfactorsandtreatmentoptionsforpatientswithhighgradechondrosarcoma
AT luteng prognosticfactorsandtreatmentoptionsforpatientswithhighgradechondrosarcoma
AT songhui prognosticfactorsandtreatmentoptionsforpatientswithhighgradechondrosarcoma
AT gaozhengchao prognosticfactorsandtreatmentoptionsforpatientswithhighgradechondrosarcoma
AT renfenggang prognosticfactorsandtreatmentoptionsforpatientswithhighgradechondrosarcoma
AT ouyangpengrong prognosticfactorsandtreatmentoptionsforpatientswithhighgradechondrosarcoma
AT wangyibin prognosticfactorsandtreatmentoptionsforpatientswithhighgradechondrosarcoma
AT zhujunjie prognosticfactorsandtreatmentoptionsforpatientswithhighgradechondrosarcoma
AT zhousonglin prognosticfactorsandtreatmentoptionsforpatientswithhighgradechondrosarcoma
AT hexijing prognosticfactorsandtreatmentoptionsforpatientswithhighgradechondrosarcoma